Proteolysis-focusing on chimeras (PROTACs) and molecular glue degraders (MGDs) are essentially the most maturely made TPD strategies. In this particular review, we concentrate on both equally preclinical experiments and scientific trials to deliver an extensive summary of the security and scientific success of PROTACs and MGDs in hematologic malign